SCHEMBL798905

SCHEMBL798905

Nc1cc(N2CCN(F)CC2C(=O)c2cccc3ccccc23)nc(N)n1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
HCRTR1 O43613 2/20 0.38
HCRTR2 O43614 2/20 0.38
USP2 O75604 1/20 0.37
KDM2B Q8NHM5 1/20 0.37
LMNA P02545 4/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 1/20 0.37
POLB P06746 2/20 0.36
PKM P14618 1/20 0.34
ATM Q13315 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654041 0.82 HTR6 (0.36) GAAHCRTR1HCRTR2KDM2BLMNA
SCHEMBL798809 0.81 GAA (0.39) GAAHCRTR1HCRTR2USP2KDM2B
SCHEMBL1695160 0.71 SHMT2 (0.37) HCRTR1HCRTR2LMNAALDH1A1MAPT
SCHEMBL1694600 0.70 GAA (0.38) GAAHCRTR1HCRTR2USP2KDM2B
SCHEMBL655440 0.64 HTR6 (0.36) GAAKDM2BLMNAALDH1A1POLB
SCHEMBL7769746 0.62 KDM4E (0.69) LMNAALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL3399717 0.62 GAA (0.56) GAAKDM2BLMNAALDH1A1MAPT
SCHEMBL28611110 0.60 GAA (0.54) GAAKDM2BLMNAALDH1A1MAPT
SCHEMBL31279942 0.59 GAA (0.60) GAAKDM2BLMNAALDH1A1MAPT
SCHEMBL11762859 0.59 GAA (0.60) GAAKDM2BLMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed